Vaccine Evening News | ​​​​​​Moderna: The vaccine is 96% effective for adolescents aged 12-17 with no serious safety issues May 7, 2021 Issue 517

US Chinese network news on May 6, Moderna said on Thursday that preliminary data showed that the company's new crown vaccine is 96% effective for 12 to 17-year-old teenagers, and there are no serious safety issues.

The company also announced on Wednesday that early data from an ongoing clinical trial showed that the "booster shot" of the new coronavirus vaccine it was developing had a good immune response to the mutant virus first discovered in South Africa and Brazil.

2

Russia's fourth new crown vaccine passed registration

According to TASS news, the Russian Ministry of Health completed the registration of the new crown vaccine "Satellite Light" on the same day.

3

The G20 summit draft promises to invest 20 billion US dollars

Funding the WHO to purchase the new crown vaccine and drug plan

Reuters news on May 6th, the conclusion of the draft summit of the leaders of the Group of Twenty (G20) countries shows that the G20 will commit for the first time to provide full funding for the World Health Organization (WHO) to distribute the new crown vaccine and medicines to poor countries.

But before the Global Health Summit in Rome on May 21, the document may be revised.

According to the draft, the G20 leaders will make a clear commitment for the first time to provide fair and sufficient funding for the Accelerated Program for Acquiring Tools to Fight the New Coronavirus (ACT-A).

G20 leaders stated in previous statements that they will address global financing needs, but did not make specific financial commitments.

Diplomats and experts preparing for the G20 summit will meet on Thursday to discuss the draft.

4

The European Commission stated that it will soon cooperate with Pfizer

Reached a contract to purchase 1.

Associated Press News on May 7, the European Commission said that it will soon reach a contract with Pfizer for the purchase of 1.

5

40% of the new crown vaccine approved by the EU for export to Japan

Nikkei News reported on May 7 that the European Commission approved the export of approximately 178 million doses of the new crown vaccine to 45 countries and regions before May 3.

6

BioNTech:

New crown vaccine patent protection will not hinder its production and supply

Singapore’s “Lianhe Zaobao” reported on May 7 that the German biotechnology company BioNTech said on Thursday that the patent protection of the new crown vaccine will not hinder its cooperation with Pfizer to develop the production or supply of the new crown vaccine.

According to Agence France-Presse, BioNTech said in a statement on Thursday local time that “patents are not a limiting factor in our vaccine production or supply.

The company warned: “If any of these requirements are not met, the manufacturer or vaccine developer cannot ensure the quality, safety and effectiveness of the vaccine.

7

National Health Commission:

A total of 29.

The National Health Commission notified that as of May 6, 31 provinces (autonomous regions and municipalities) and the Xinjiang Production and Construction Corps had reported a total of 29.
734 million doses of new crown virus vaccine.
(Source: Interface News)

8

Hong Kong will start from May 12

Shorten the quarantine period for passengers who have been vaccinated

According to Bloomberg's news on the 7th, Hong Kong will shorten the quarantine period for passengers who have finished vaccines from May 12.
According to a report on the website of Radio Hong Kong on the 7th, after the completion of two doses of vaccine on the 14th, no variant virus was involved, and the home quarantine was changed to 7 days.